An open label, non comparative, multicenter clinical trial to observe the efficacy and safety of olmesartan medoxomil and hydrochlorothiazide combined with amlodipine in Chinese patients with mild to moderate essential hypertension, who had insufficient response for amlodipine monotherapy.

Trial Profile

An open label, non comparative, multicenter clinical trial to observe the efficacy and safety of olmesartan medoxomil and hydrochlorothiazide combined with amlodipine in Chinese patients with mild to moderate essential hypertension, who had insufficient response for amlodipine monotherapy.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2016

At a glance

  • Drugs Amlodipine (Primary) ; Olmesartan medoxomil (Primary) ; Olmesartan medoxomil/hydrochlorothiazide (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date 29 Mar 2013 added as reported by Chinese Clinical Trial Register.
    • 06 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top